CompletedPhase 3NCT00004402

Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis

Studying Albers-Schönberg osteopetrosis

Last synced from ClinicalTrials.gov May 22, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: FDA Office of Orphan Products Development
Principal Investigator: L. Lyndon Key, Jr.
Medical University of South Carolina
Intervention: calcitriol(drug)
Enrollment: 30 enrolled
Eligibility: 10 years · All sexes
Timeline: 1999 – 2000

Collaborators

Medical University of South Carolina

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004402 on ClinicalTrials.gov

← Back to all trials